HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veerle Bossuyt Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

11/2017Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veerle Bossuyt Research Topics

Disease

23Neoplasms (Cancer)
01/2022 - 03/2011
20Breast Neoplasms (Breast Cancer)
12/2021 - 03/2011
4Pathologic Complete Response
02/2016 - 05/2014
3Neoplasm Metastasis (Metastasis)
01/2022 - 07/2005
3Triple Negative Breast Neoplasms
12/2021 - 01/2013
3Carcinoma (Carcinomatosis)
11/2018 - 09/2015
2Noninfiltrating Intraductal Carcinoma (DCIS)
01/2018 - 09/2017
1Schmid-Fraccaro syndrome
01/2022
1Avian Reticuloendotheliosis
01/2022
1Lung Neoplasms (Lung Cancer)
01/2020
1Ductal Carcinoma
11/2018
1Carcinoma in Situ
10/2018
1Mesothelioma
11/2017
1Melanoma (Melanoma, Malignant)
11/2017
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017
1Brain Neoplasms (Brain Tumor)
11/2017
1Extranodal Extension
09/2017
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
03/2017
1Adenocarcinoma
09/2013
1Lymphatic Metastasis
02/2010

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
10/2018 - 03/2011
3Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2013
3Messenger RNA (mRNA)IBA
01/2019 - 01/2013
3Estrogen ReceptorsIBA
01/2018 - 03/2011
3Trastuzumab (Herceptin)FDA Link
02/2016 - 05/2014
3130-nm albumin-bound paclitaxelIBA
02/2016 - 05/2014
2Biological ProductsIBA
01/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2019 - 02/2016
2Phenobarbital (Luminal)FDA Link
01/2018 - 01/2013
2Hematoxylin (Haematoxylon)IBA
09/2017 - 03/2011
2Eosine Yellowish-(YS) (Eosin)IBA
09/2017 - 03/2011
2DNA (Deoxyribonucleic Acid)IBA
03/2017 - 09/2013
22- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
12/2015 - 03/2011
2Monoclonal AntibodiesIBA
04/2015 - 05/2014
1CytokinesIBA
01/2022
1ChromatinIBA
01/2022
1Lysine (L-Lysine)FDA Link
01/2022
1Capecitabine (Xeloda)FDA Link
12/2021
1AnthracyclinesIBA
12/2021
1taxaneIBA
12/2021
1TropomyosinIBA
10/2021
1Phosphotransferases (Kinase)IBA
10/2021
1larotrectinibIBA
10/2021
1entrectinibIBA
10/2021
1CateninsIBA
01/2021
1Aurora Kinase AIBA
01/2021
1atezolizumabIBA
01/2020
1human ERBB2 proteinIBA
01/2019
1ORALIT (ORS)IBA
11/2018
1Pharmaceutical PreparationsIBA
04/2016
1Bevacizumab (Avastin)FDA Link
02/2016
1B7-H1 AntigenIBA
04/2015
1Hormones (Hormone)IBA
04/2015
1Immune Checkpoint ProteinsIBA
04/2015
1Carboplatin (JM8)FDA LinkGeneric
05/2014
1Androgen Receptors (Androgen Receptor)IBA
01/2013
1Insulin-Like PeptidesIBA
01/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
1OsseusIBA
02/2010
1Dihydrotachysterol (AT 10)IBA
07/2005

Therapy/Procedure

11Therapeutics
01/2022 - 03/2011
8Neoadjuvant Therapy
01/2020 - 05/2014
6Drug Therapy (Chemotherapy)
12/2021 - 02/2010
2Segmental Mastectomy (Lumpectomy)
01/2017 - 08/2015
1Mastectomy (Mammectomy)
01/2018
1Immunotherapy
11/2017
1Combination Drug Therapy (Combination Chemotherapy)
02/2016
1Biological Therapy
02/2016
1Aftercare (After-Treatment)
09/2015
1Curettage
09/2013